Real-time SARS-CoV-2 diagnostic and variants tracking over multiple candidates using nanopore DNA sequencing

Abstract Since December 2019, a novel coronavirus responsible for a severe acute respiratory syndrome (SARS-CoV-2) is accountable for a major pandemic situation. The emergence of the B.1.1.7 strain, as a highly transmissible variant has accelerated the world-wide interest in tracking SARS-CoV-2 vari...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: François Stüder, Jean-Louis Petit, Stefan Engelen, Marco Antonio Mendoza-Parra
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/aae11a66f3d94b1294c5335129e11b77
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aae11a66f3d94b1294c5335129e11b77
record_format dspace
spelling oai:doaj.org-article:aae11a66f3d94b1294c5335129e11b772021-12-02T18:49:36ZReal-time SARS-CoV-2 diagnostic and variants tracking over multiple candidates using nanopore DNA sequencing10.1038/s41598-021-95563-w2045-2322https://doaj.org/article/aae11a66f3d94b1294c5335129e11b772021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-95563-whttps://doaj.org/toc/2045-2322Abstract Since December 2019, a novel coronavirus responsible for a severe acute respiratory syndrome (SARS-CoV-2) is accountable for a major pandemic situation. The emergence of the B.1.1.7 strain, as a highly transmissible variant has accelerated the world-wide interest in tracking SARS-CoV-2 variants’ occurrence. Similarly, other extremely infectious variants, were described and further others are expected to be discovered due to the long period of time on which the pandemic situation is lasting. All described SARS-CoV-2 variants present several mutations within the gene encoding the Spike protein, involved in host receptor recognition and entry into the cell. Hence, instead of sequencing the whole viral genome for variants’ tracking, herein we propose to focus on the SPIKE region to increase the number of candidate samples to screen at once; an essential aspect to accelerate diagnostics, but also variants’ emergence/progression surveillance. This proof of concept study accomplishes both at once, population-scale diagnostics and variants' tracking. This strategy relies on (1) the use of the portable MinION DNA sequencer; (2) a DNA barcoding and a SPIKE gene-centered variant’s tracking, increasing the number of candidates per assay; and (3) a real-time diagnostics and variant’s tracking monitoring thanks to our software RETIVAD. This strategy represents an optimal solution for addressing the current needs on SARS-CoV-2 progression surveillance, notably due to its affordable implementation, allowing its implantation even in remote places over the world.François StüderJean-Louis PetitStefan EngelenMarco Antonio Mendoza-ParraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
François Stüder
Jean-Louis Petit
Stefan Engelen
Marco Antonio Mendoza-Parra
Real-time SARS-CoV-2 diagnostic and variants tracking over multiple candidates using nanopore DNA sequencing
description Abstract Since December 2019, a novel coronavirus responsible for a severe acute respiratory syndrome (SARS-CoV-2) is accountable for a major pandemic situation. The emergence of the B.1.1.7 strain, as a highly transmissible variant has accelerated the world-wide interest in tracking SARS-CoV-2 variants’ occurrence. Similarly, other extremely infectious variants, were described and further others are expected to be discovered due to the long period of time on which the pandemic situation is lasting. All described SARS-CoV-2 variants present several mutations within the gene encoding the Spike protein, involved in host receptor recognition and entry into the cell. Hence, instead of sequencing the whole viral genome for variants’ tracking, herein we propose to focus on the SPIKE region to increase the number of candidate samples to screen at once; an essential aspect to accelerate diagnostics, but also variants’ emergence/progression surveillance. This proof of concept study accomplishes both at once, population-scale diagnostics and variants' tracking. This strategy relies on (1) the use of the portable MinION DNA sequencer; (2) a DNA barcoding and a SPIKE gene-centered variant’s tracking, increasing the number of candidates per assay; and (3) a real-time diagnostics and variant’s tracking monitoring thanks to our software RETIVAD. This strategy represents an optimal solution for addressing the current needs on SARS-CoV-2 progression surveillance, notably due to its affordable implementation, allowing its implantation even in remote places over the world.
format article
author François Stüder
Jean-Louis Petit
Stefan Engelen
Marco Antonio Mendoza-Parra
author_facet François Stüder
Jean-Louis Petit
Stefan Engelen
Marco Antonio Mendoza-Parra
author_sort François Stüder
title Real-time SARS-CoV-2 diagnostic and variants tracking over multiple candidates using nanopore DNA sequencing
title_short Real-time SARS-CoV-2 diagnostic and variants tracking over multiple candidates using nanopore DNA sequencing
title_full Real-time SARS-CoV-2 diagnostic and variants tracking over multiple candidates using nanopore DNA sequencing
title_fullStr Real-time SARS-CoV-2 diagnostic and variants tracking over multiple candidates using nanopore DNA sequencing
title_full_unstemmed Real-time SARS-CoV-2 diagnostic and variants tracking over multiple candidates using nanopore DNA sequencing
title_sort real-time sars-cov-2 diagnostic and variants tracking over multiple candidates using nanopore dna sequencing
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/aae11a66f3d94b1294c5335129e11b77
work_keys_str_mv AT francoisstuder realtimesarscov2diagnosticandvariantstrackingovermultiplecandidatesusingnanoporednasequencing
AT jeanlouispetit realtimesarscov2diagnosticandvariantstrackingovermultiplecandidatesusingnanoporednasequencing
AT stefanengelen realtimesarscov2diagnosticandvariantstrackingovermultiplecandidatesusingnanoporednasequencing
AT marcoantoniomendozaparra realtimesarscov2diagnosticandvariantstrackingovermultiplecandidatesusingnanoporednasequencing
_version_ 1718377580780847104